Pharmaceutical - GlaxoSmithKline, Pharmaceutical

Filter

Popular Filters

1 to 25 of 419 results

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

GSK joins with research councils in UK and South Africa to tackle non-communicable diseases in Africa

09-09-2014

UK pharma giant GlaxoSmithKline today announced a £5 million ($8.2 million) collaboration with the UK…

FinancialGlaxoSmithKlinePharmaceuticalResearchSouth AfricaUK

GSK reports positive Phase III results of its mepolizumab in asthma

GSK reports positive Phase III results of its mepolizumab in asthma

08-09-2014

UK pharma major GlaxoSmithKline has reported positive data from its Phase III asthma studies of mepolizumab,…

GlaxoSmithKlineGSKImmunosuppressantsmepolizumabMepolizumabPharmaceuticalResearchRespiratory and PulmonaryUK

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

EU marketing authorization for ViiV Healthcare HIV drug Triumeq

03-09-2014

The European Commission has granted marketing authorization for ViiV Healthcare’s Triumeq (dolutegravir…

Anti-viralsEuropeGlaxoSmithKlinePharmaceuticalRegulationTriumeqViiV Healthcare

Ebola vaccine trials fast-tracked by international consortium, including GSK

Ebola vaccine trials fast-tracked by international consortium, including GSK

28-08-2014

In the wake of the devastating outbreak of Ebola in West Africa, an unprecedented international consortium…

At preventing the diseaseBiologyDiseaseEbola epidemicGlaxoSmithKlineMedicinePharmaceuticalResearchTropical diseasesVaccines

FDA backs added indication for GSK’s Promacta

FDA backs added indication for GSK’s Promacta

27-08-2014

The Food and Drug Administration has approved UK pharma giant GlaxoSmithKline’s supplemental New Drug…

GlaxoSmithKlineHematologyLigand PharmaceuticalsPharmaceuticalPromactaRare diseasesRegulationRevoladeUSA

ViiV Healthcare gains FDA approval for HIV drug Triumeq

ViiV Healthcare gains FDA approval for HIV drug Triumeq

23-08-2014

The US Food and Drug Administration has approved Triumeq (abacavir 600mg, dolutegravir 50mg and lamivudine…

Anti-viralsGlaxoSmithKlinePfizerPharmaceuticalRegulationShionogiTriumeqUSAViiV Healthcare

US FDA backs approval of GSK’s Arnuity Ellipta for asthma

US FDA backs approval of GSK’s Arnuity Ellipta for asthma

21-08-2014

UK pharma giant GlaxoSmithKline revealed late yesterday that the US Food and Drug Administration has…

Arnuity ElliptaGlaxoSmithKlinePharmaceuticalRegulationRespiratory and PulmonaryUSA

Private equity firms could be looking to acquire mature GSK and Sanofi brands

Private equity firms could be looking to acquire mature GSK and Sanofi brands

05-08-2014

Private equity groups KKR and Warburg Pincus are considering a $10 billion plan to buy drug brands from…

Business FinanceFinancialGlaxoSmithKlineGlobalMylanPharmaceuticalSanofi

Reckitt Benckiser to spin out pharma; GSK views Consumer options

Reckitt Benckiser to spin out pharma; GSK views Consumer options

28-07-2014

UK-based consumer goods giant Reckitt Benckiser plans to spin off its USA-based pharmaceutical business,…

FinancialGlaxoSmithKlineMergers & AcquisitionsNeurologicalPharmaceuticalReckitt BenckiserSuboxoneUK

Pharmaceuticals, a strategic sector for the UK government

Pharmaceuticals, a strategic sector for the UK government

28-07-2014

Britain’s pharmaceuticals sector, which includes AstraZeneca and GlaxoSmithKline, two drugmakers among…

AstraZenecaEconomy of the United KingdomFinancialGlaxoSmithKlineMarkets & MarketingPharmaceuticalResearchUK

GSK files EU regulatory submission for RTS,S malaria vaccine candidate

24-07-2014

UK pharma giant GlaxoSmithKline announced today that it has submitted a regulatory application to the…

EuropeGlaxoSmithKlinePharmaceuticalRegulationRest of the WorldRTS,STropical diseasesVaccines

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

GlaxoSmithKline slashes forecast as 2nd-qtr sales and earnings fall sharply

23-07-2014

UK pharma giant GlaxoSmithKline saw its shares fall 3.9% to £45.94 shortly after the company reported…

FinancialFluticasone propionateGlaxoSmithKlinePharmaceuticalPulmonologyUK

Seven pharma companies offer up compounds to UK researchers

Seven pharma companies offer up compounds to UK researchers

22-07-2014

UK researchers will be granted access to a ‘virtual library’ of deprioritized pharmaceutical compounds…

AstraZenecaEli LillyGlaxoSmithKlineJanssenMedical Research CouncilPfizerPharmaceuticalResearchTakeda PharmaceuticalUCBUK

Global epileptic anticonvulsants market - 2014-2020

Global epileptic anticonvulsants market - 2014-2020

16-07-2014

North America dominates the global epileptic anticonvulsants market and is followed by Europe, according…

Abbott LaboratoriesAsia PacificBusiness FinanceEpilepsyGlaxoSmithKlineGlobalHealth Medical PharmaHealth Medical PharmaJohnson & JohnsonMarkets & MarketingNeurologicalNovartisPfizerPharmaceuticalUCB

Codexis leaps on licensing deal with GlaxoSmithKline

Codexis leaps on licensing deal with GlaxoSmithKline

15-07-2014

Codexis, a developer of biocatalysts for the pharmaceutical and fine chemical industries, saw its share…

CodeEvolverCodeEvolver protein engineering platform technologyCodexisGlaxoSmithKlineLicensingPharmaceuticalProductionUK

GSK spies indicted in China for illegally obtaining information

GSK spies indicted in China for illegally obtaining information

15-07-2014

A couple allegedly working for UK pharma major GlaxoSmithKline in China have been indicted in Shanghai…

ChinaGlaxoSmithKlineGSKLegalPharmaceuticalXinhua News AgencyXinhua News Agency

US nephrologists view hyperphosphatemia treatment

US nephrologists view hyperphosphatemia treatment

11-07-2014

Surveyed nephrologists report awareness of the US Food and Drug Administration's approval of Vifor Fresenius…

AmgenFreseniusGlaxoSmithKlineLa Jolla PharmaceuticalMarkets & MarketingNephrology and HepatologyOPKO HealthPharmaceuticalRayaldeeSensiparUSAvelcalcetideVelphoroVenoferVifor Pharma

GSK receives EU approval for Mekinist for melanoma

GSK receives EU approval for Mekinist for melanoma

04-07-2014

The European Commission has granted marketing authorization for UK pharma giant GlaxoSmithKline’s Mekinist…

EuropeGlaxoSmithKlineMekinistOncologyPharmaceuticalRegulation

GSK’s Anoro Ellipta approved in Japan for COPD

GSK’s Anoro Ellipta approved in Japan for COPD

04-07-2014

UK pharma giant GlaxoSmithKline and US partner Theravance said this morning that the Japanese Ministry…

Anoro ElliptaGlaxoSmithKlineJapanPharmaceuticalRespiratory and PulmonaryTheravance

1 to 25 of 419 results

Back to top